<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">OTD</journal-id><journal-title-group><journal-title>Oncology Treatment Discovery</journal-title></journal-title-group><issn>3083-4996</issn><eissn>2981-8079</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/otd.v4i1.14268</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Exploration and Research on a New Model for Early Lung Cancer Screening</title><url>https://artdesignp.com/journal/OTD/4/1/10.26689/otd.v4i1.14268</url><author>LiYa,XuBin</author><pub-date pub-type="publication-year"><year>2026</year></pub-date><volume>4</volume><issue>1</issue><history><date date-type="pub"><published-time>2026-03-18</published-time></date></history><abstract>Objective: To explore scientifically feasible management models and methods for the assessment, screening, early diagnosis, and early treatment of individuals at high risk for lung cancer. Methods: Seven communities within the Jinyinshan area of our city, namely Xiliuwan, Ligongxiang, Huxingshan, Zhushan, Xiufeng, Jinyinshan, and Sanyantang, were selected as the screening regions for this project. The screening methods followed the “Technical Plan for Lung Cancer Screening in Hunan Province (2021 Edition)”, involving low-dose spiral computed tomography (CT) and carcinoembryonic antigen (CEA) testing for clinical screening of high-risk individuals. The positive screening rate and lung cancer positive rate were calculated, and positive cases were subjected to stratified management and treatment. Results: From January 1, 2024, to December 31, 2024, a total of 2,626 individuals completed questionnaires, including 1,625 males and 1,001 females. Among them, 681 individuals were identified as being at high risk for lung cancer, accounting for 25.93% of the total screened population, with 456 males (66.96%) and 225 females (33.04%). The detection rate of suspected lung cancer was higher with combined testing (3.00%) compared to CT alone (2.00%) or CEA alone (1.60%), suggesting that combined testing improves diagnostic accuracy. A total of 500 cases underwent low-dose spiral CT combined with CEA testing, with 15 suspected cases of lung cancer identified, resulting in a detection rate of 2.20%. Conclusion: Early screening for lung cancer facilitates early detection, diagnosis, and treatment, reduces incidence and mortality rates, improves patients’ quality of life, and alleviates societal burdens.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Li S, Pan R, Li Q, et al., 2024, Analysis of Factors Influencing the Willingness for Early Lung Cancer Screening Among Community Residents in Dongguan City. Journal of Nurses Training, 39(1): 89–92.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Wolf AMD, Oeffinger KC, Shih TY, et al., 2024, Screening for Lung Cancer: 2023 Guideline Update from the American Cancer Society. CA: A Cancer Journal for Clinicians, 74(1): 50–81.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Zhang X, Zhang J, Wang X, et al., 2024, Research Progress in Early Lung Cancer Screening. Health Examination and Management, 21(3): 44–50 + 106.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Zhao X, 2024, Study on Low-Dose CT Early Lung Cancer Screening in 2,000 Asymptomatic Individuals in Lanzhou City. Imaging Research and Medical Applications, 8(4): 100–102.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Lam DC, Liam CK, Andarini S, et al., 2023, Lung Cancer Screening in Asia: An Expert Consensus Report. Journal of Thoracic Oncology, 18(10): 1303–1322.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Wang Z, Guo W, Zhen D, 2022, Application of Low-Dose Chest CT in the Screening of Pulmonary Nodules and Early Lung Cancer. Journal of Clinical Radiology, 41(7): 1298–1302.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Zhong D, Sidorenkov G, Jacobs C, et al., 2024, Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial. Radiology, 313(1): e240535.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Zhang S, Dai T, Jiang J, 2023, Application of Low-Dose Spiral CT in Early Lung Cancer Screening. China Medical Device Information, 29(15): 54–57.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Liang W, Li C, He J, 2021, Precision Exploration of Early Screening and Diagnosis of Lung Cancer. Chinese Journal of Clinical Oncology, 48(10): 506–510.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Kim J, Lee H, Huang BW, 2022, Lung Cancer: Diagnosis, Treatment Principles, and Screening. American Family Physician, 105(5): 487–494.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Yang Y, Guo X, Fan Y, et al., 2024, Evaluation of the Screening Effectiveness of the Early Diagnosis and Treatment Project for Lung Cancer Among Community Residents in Nanshan District, Shenzhen City. Chinese Journal of Public Health, 40(11): 1312–1317.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Veeramachaneni NK, 2022, Commentary: Computed Tomography Screening for Lung Cancer at Large in China: Early Cure or Definitive Overtreatment. Journal of Thoracic and Cardiovascular Surgery, 163(2): 466–467.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Zhao C, 2022, Research Progress in the Selection of High-Risk Populations for Early Lung Cancer Screening and the Application of Low-Dose CT in Screening. Capital Food and Medicine, 29(15): 029.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Zhu Z, 2022, Clinical Application of MDCT in the Diagnosis of Early Lung Cancer Screening. Modern Medical Imaging, 31(12): 2189–2192.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
